Form 8-K - Current report:
SEC Accession No. 0001628280-20-008448
Filing Date
2020-05-27
Accepted
2020-05-27 06:53:58
Documents
17
Period of Report
2020-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K guardant-8xk5262020.htm   iXBRL 8-K 55913
2 EXHIBIT 10.1 exhibit101-guardant8xk.htm EX-10.1 113813
3 EXHIBIT 10.2 exhibit102-guardant8xk.htm EX-10.2 21477
9 guardantlogoa02.jpg GRAPHIC 75609
  Complete submission text file 0001628280-20-008448.txt   469480

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20200526.xsd EX-101.SCH 4524
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gh-20200526_cal.xml EX-101.CAL 703
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gh-20200526_def.xml EX-101.DEF 1553
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20200526_lab.xml EX-101.LAB 26147
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20200526_pre.xml EX-101.PRE 13659
14 EXTRACTED XBRL INSTANCE DOCUMENT guardant-8xk5262020_htm.xml XML 4457
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 20912713
SIC: 8071 Services-Medical Laboratories